These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 21778406)

  • 1. Pathway and mechanism of drug binding to G-protein-coupled receptors.
    Dror RO; Pan AC; Arlow DH; Borhani DW; Maragakis P; Shan Y; Xu H; Shaw DE
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13118-23. PubMed ID: 21778406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features of β2 adrenergic receptor: crystal structures and beyond.
    Bang I; Choi HJ
    Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation mechanism of the β2-adrenergic receptor.
    Dror RO; Arlow DH; Maragakis P; Mildorf TJ; Pan AC; Xu H; Borhani DW; Shaw DE
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18684-9. PubMed ID: 22031696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
    Selvam B; Wereszczynski J; Tikhonova IG
    Chem Biol Drug Des; 2012 Aug; 80(2):215-26. PubMed ID: 22530954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allosteric modulator binds to a conformational hub in the β
    Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
    Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lipid composition on the structural stability of g-protein coupled receptor.
    Mahmood I; Liu X; Neya S; Hoshino T
    Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors.
    Nikiforovich GV; Taylor CM; Marshall GR; Baranski TJ
    Proteins; 2010 Feb; 78(2):271-85. PubMed ID: 19731375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction.
    Cang X; Yang L; Yang J; Luo C; Zheng M; Yu K; Yang H; Jiang H
    Proteins; 2014 May; 82(5):760-70. PubMed ID: 24265091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell signalling: Binding the receptor at both ends.
    Sprang SR
    Nature; 2011 Jan; 469(7329):172-3. PubMed ID: 21228868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Markov State Model and Path Metadynamics Approach To Characterize Drug Binding Processes.
    Bernetti M; Masetti M; Recanatini M; Amaro RE; Cavalli A
    J Chem Theory Comput; 2019 Oct; 15(10):5689-5702. PubMed ID: 31436987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
    Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
    Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.
    Vanni S; Neri M; Tavernelli I; Rothlisberger U
    Biochemistry; 2009 Jun; 48(22):4789-97. PubMed ID: 19378975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamic process of β(2)-adrenergic receptor activation.
    Nygaard R; Zou Y; Dror RO; Mildorf TJ; Arlow DH; Manglik A; Pan AC; Liu CW; Fung JJ; Bokoch MP; Thian FS; Kobilka TS; Shaw DE; Mueller L; Prosser RS; Kobilka BK
    Cell; 2013 Jan; 152(3):532-42. PubMed ID: 23374348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
    Isin B; Estiu G; Wiest O; Oltvai ZN
    PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
    Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
    Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.